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Hypoxia counteracts taxol-induced apoptosis in
MDA-MB-231 breast cancer cells: role of autophagy
and JNK activation
A Notte1, N Ninane1, T Arnould1 and C Michiels*,1
Cancer cell resistance against chemotherapy is still a heavy burden to improve anticancer treatments. Autophagy activation and
the development of hypoxic regions within the tumors are known to promote cancer cell resistance. Therefore, we sought to
evaluate the role of autophagy and hypoxia on the taxol-induced apoptosis in MDA-MB-231 breast cancer cells. The results
showed that taxol induced apoptosis after 16 h of incubation, and that hypoxia protected MDA-MB-231 cells from taxol-induced
apoptosis. In parallel, taxol induced autophagy activation already after 2 h of incubation both under normoxia and hypoxia.
Autophagy activation after taxol exposure was shown to be a protective mechanism against taxol-induced cell death both under
normoxia and hypoxia. However, at longer incubation time, the autophagic process reached a saturation point under normoxia
leading to cell death, whereas under hypoxia, autophagy flow still correctly took place allowing the cells to survive. Autophagy
induction is induced after taxol exposure via mechanistic target of rapamycin (mTOR) inhibition, which is more important in cells
exposed to hypoxia. Taxol also induced c-Jun N-terminal kinase (JNK) activation and phosphorylation of its substrates B-cell
CLL/lymphoma 2 (Bcl2) and BCL2-like 1 (BclXL) under normoxia and hypoxia very early after taxol exposure. Bcl2 and BclXL
phosphorylation was decreased more importantly under hypoxia after long incubation time. The role of JNK in autophagy and
apoptosis induction was studied using siRNAs. The results showed that JNK activation promotes resistance against taxol-
induced apoptosis under normoxia and hypoxia without being involved in induction of autophagy. In conclusion, the resistance
against taxol-induced cell death observed under hypoxia can be explained by a more effective autophagic flow activated via the
classical mTOR pathway and by a mechanism involving JNK, which could be dependent on Bcl2 and BclXL phosphorylation but
independent of JNK-induced autophagy activation.
Cell Death and Disease (2013) 4, e638; doi:10.1038/cddis.2013.167; published online 16 May 2013
Subject Category: Cancer
Accumulating evidence points to the fact that tumor micro-
environment, which is very different from the one present in
normal tissue, influences the pathophysiological character-
istics of the tumor. A common feature of the environment
associated in solid tumors is the presence of hypoxic areas
within the tumor mass that develop when the high proliferation
rate of tumor cells outstrips vasculature development.1 Tumor
hypoxia is associated with a decrease in antitumor treatment
efficacy such as radiation therapy and chemotherapy, and
with a poor prognosis.2–4 More and more data showed that
another process is also involved in the resistance against
chemotherapy-induced cell death, which is autophagy.
Autophagy is a highly conserved process during which parts
of the cytoplasm including damaged, superfluous organelles
or long-lived proteins are sequestered into double-membrane
vesicles known as autophagosomes. These autophago-
somes fused with lysosomes and their content is degraded
by lysosomal proteases. This process allows energy supply
during starvation through macromolecular building block
recycling, defining autophagy as a protective mechanism.
However, in cancer development, autophagy has been shown
as having a dual role.5,6 In some cases, autophagy promotes
tumorigenesis, but in others, autophagy is a tumor-suppres-
sive mechanism. Therefore, one question that has emerged
from recent studies is whether autophagy displays a cytotoxic
or cytoprotective role. Experimental evidence coexists to
support these two hypotheses.7–13 In parallel, the implication
of autophagy in cell death processes was reevaluated, as a
vast study testing 1400 compounds concluded that not a
single antitumor compound turned out to kill tumor cells
through the induction of autophagy.14 Recent reports also
showed that hypoxia is able tomodulate autophagy, leading to
cell survival and resistance against anticancer therapies.15–19
This issue is evenmore complex as themolecular pathways
regulating autophagy and apoptosis are interconnected. The
modulation of one mechanism influences the execution of the
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second one and vice-versa.20 Moreover, autophagic and
apoptotic features can be observed in the very same cell,
and both pathways share several key molecular regula-
tors.21 One of them is beclin 1, originally discovered as a
B-cell CLL/lymphoma 2 (Bcl2)-interacting protein.
22 Beclin 1
constitutively interacts with Bcl2 and BCL2-like 1 (BclXL) in
the endoplasmic reticulum. Bcl2 and BclXL act as inhibitors of
autophagy, as the binding of beclin 1 to them interferes with
beclin 1/phosphatidylinositol 3-kinase VPS34 complex for-
mation. Autophagy can be activated by different ways: in
addition to the mechanistic target of rapamycin (mTOR)
pathway, pro-apoptotic proteins such as Bcl2-associated
agonist of cell death, BCL2-like 11 and BCL2/adenovirus
E1B 19 kDa-interacting protein 3 (Bnip3) can interact with
Bcl2 and BclXL proteins,
23 whereas the kinase c-Jun
N-terminal kinase (JNK) can phosphorylate Bcl2 and
BclXL, leading to Bcl2/BclXL-beclin 1 complex disruption,
beclin 1 release and subsequent autophagy activation.24,25.
Nevertheless, we do not know how hypoxia and autophagy
work together to modulate cancer cell response to che-
motherapy-induced cell death. The aim of this study is to
understand the implication of hypoxia and autophagy in the
resistance of cancer cells against chemotherapy, and also to
understand which mechanisms promote cell survival under
hypoxia. For this purpose, human breast cancer MDA-MB-
231 cells were exposed to the chemotherapeutic agent
paclitaxel (here refered as taxol); taxol being one of the
most active agents used in the treatment of metastatic
breast cancer.26
Results
Hypoxia protects MDA-MB-231 cells against taxol-induced
apoptosis and cell death. Many studies have already
shown that hypoxia influences drug-induced apoptosis
differently according to the cancer cell lines27 and confers
resistance against chemotherapy-induced apoptosis in
numerous solid tumors.28–30 In order to study the effect of
hypoxia on taxol-induced apoptosis, MDA-MB-231 cells were
incubated under normoxia or hypoxia with or without taxol. It
has to be noted that, in these conditions, hypoxia did lead to
hypoxia-inducible factor-1 activation and that taxol had very
low influence on this process (Supplementary data 1).
Caspase 3 and poly-(ADP-ribose) polymerase (PARP)
cleavage was assessed after 2, 4, 8 16 and 24 h of incubation
(Figure 1a) and caspase 3/7 activity was measured after 16 h
of incubation (Figure 1b). The effect of hypoxia on taxol-
induced cell death was also studied by measuring cytotoxi-
city after 40 h (Figure 1c). No increase in caspase 3 activity,
caspase 3 and PARP cleavage or in cytotoxicity was
observed in cells exposed to hypoxia alone. Taxol did trigger
apoptosis after 16 h of incubation as shown by an increase in
caspase 3 and PARP cleavage, and in caspase 3 activity. In
parallel, taxol induced a significant increase in cytotoxicity as
shown by an increase in lactate dehydrogenase (LDH)
release after 40 h. Hypoxia inhibited the taxol-induced
apoptosis and cell death as shown by a decrease in caspase
3 and PARP cleavage, as well as in caspase 3 activity and
cytotoxicity. These data demonstrate that hypoxia is able to
protect MDA-MB-231 cells against taxol-induced apoptosis
and cell death.
Taxol activates autophagy and hypoxia modulates
taxol-induced autophagy. Autophagy can be activated
after exposure to hypoxia31 or to chemotherapeutic drugs12,32
including taxol.33 In order to evaluate the effect of hypoxia
and/or taxol on autophagy, the abundance of microtubule-
associated protein 1 light chain 3 alpha (LC3) II and p62 was
assessed by western blotting (Figure 2a). P62 is a protein
known to be a selective substrate for degradation during
autophagy.34 Taxol induced the conversion of LC3I to LC3II
already after 4 h and the amount of LC3II increased with the
incubation time. Hypoxia alone did not influence the taxol-
induced LC3II conversion. After 4 h, a decrease in p62
abundance was observed in cells incubated in the presence
of taxol compared with control cells. This decrease in p62
abundance could correspond to early autophagic degradation.
Unexpectedly, an increase in p62 abundance was observed
after 16 and 24h in cells incubated in the presence of taxol.
This increase was lower in cells incubated under hypoxia.
These results suggest that taxol induced early autophagy
activation, which seems to be inhibited after 16 and 24h under
normoxia and to a lesser extent under hypoxia.
LC3 relocalization in the membranes of autophagic
vacuoles and the fusion of autophagosomes with lysosomes
was studied using immunofluorescence staining for LC3 as a
marker for autophagosomes and lysosomal-associated mem-
brane protein 1 (LAMP1) as a marker of lysosomes
(Figure 2b). LC3I is a cytosolic protein that is recruited to
the autophagosomemembranes once autophagy is activated,
giving a punctuate labeling. In control cells, we observed a
diffuse LC3 labeling and a vacuole-like LAMP1 labeling. Taxol
and to a lesser extent hypoxia alone induced an increase in
LC3 punctuation and, in some cases, the LC3 labeling is
associated to large vesicles that may correspond to swollen
autophagosomes. Partial colocalization between LC3 and
LAMP1 labeling was also observed after exposure to taxol
under normoxia and hypoxia, meaning that the fusion
between lysosomes and autophagosomes took place. Recent
reports have shown that the microtubule network is important
for autophagosome–lysosome fusion and for a correct
degradation into autolysosomes.35–37 Autophagic degrada-
tion was then studied by monitoring lysosomal activity using
the DQ-bovine serum albumin (BSA) fluorescent dye
(Figure 2c). This dye is strongly selfquenched. Proteolysis of
the BSA conjugates results in dequenching and release of
protein fragments that contain isolated fluorophores, which
are brightly fluorescent. In order to take into account only
autophagy-dependent protease activity, DQ-Green-BSA pro-
teolysis was also measured in the presence of bafilomycin A,
an inhibitor of the vacuolar Hþ -ATPase blocking the activity
of the pH-dependent lysosomal proteases. Results showed
that autophagic degradation was clearly enhanced after
exposure to taxol under normoxia and hypoxia. Moreover,
DQ-BSA emission was detected in the lysosomes, as shown
by colocalization with lysotracker red (Supplementary data 2).
These results indicate that even if the microtubule network is
disturbed, taxol exposure induced an increase in autophagic
degradation under normoxia and hypoxia.
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Autophagy reaches a saturation point under normoxia
after long incubation time. In order to explain the p62
accumulation observed after taxol treatment, p62 mRNA
expression was assessed after 16 and 24 h (Supplementary
data 3A). An increase in p62 mRNA expression was
observed in cells exposed to taxol. This increase was lower
in cells exposed to hypoxia. We investigated whether p62
accumulation observed at the protein level was due to
transcriptional induction by incubating cells with actinomycin D
(Supplementary data 3B and C), a transcription inhibitor.
Actinomycin D abrogated the taxol-induced p62 mRNA
expression and p62 protein accumulation, indicating that
the increase in p62 protein abundance resulted at least in
part from an increase in p62 mRNA expression. In parallel,
the autophagic flow was evaluated by measuring p62 protein
abundance after the addition of bafilomycin A or pepstatin
AþE64D during the incubation. PepstatinA and E64D inhibit
lysosomal proteases. After incubation in the presence of
these molecules, no increase in p62 protein abundance was
observed in cells incubated with taxol under normoxia,
whereas an increase in p62 protein abundance was
observed in cells incubated with taxol under hypoxia
(Supplementary data 4A and B). These results suggest that
autophagy degradation reached a saturation point under
normoxia and this was not the case under hypoxia. More-
over, addition of bafilomycin A resulted in an increase in p62
mRNA expression (Supplementary data 4C), indicating that a
disruption of the autophagic flow leads to induction of p62
expression. In conclusion, the increase in p62 abundance
observed after taxol exposure could result from a perturba-
tion in the autophagic flow. We suggest that in cells exposed
to taxol under normoxia, autophagy is saturated after long
incubation time leading to p62 accumulation and incorrect
remediation of the stress induced by taxol. On the opposite,
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Figure 1 Hypoxia protects MDA-MB-231 cells against taxol-induced apoptosis and cell death. MDA-MB-231 cells were incubated under normoxia (N) or hypoxia (H)
without (C) or with taxol (T) at 50mM. (a) After 2, 4, 8, 16 and 24 h of incubation, cleaved caspase 3 and PARP-1 were detected in total cell extracts by western blotting
analysis, using specific antibodies. b-actin was used to assess the total amount of proteins loaded on the gel. The graphs below represent the quantification of cleaved PARP
and cleaved caspase 3 abundance normalized to the corresponding b-actin. (b) After 16 h of incubation, caspase 3 and 7 activity was assayed by measuring fluorescence
intensity associated to free AFC released from the cleavage of caspase 3 and 7 substrate Ac-DEVD-AFC. Data are expressed in relative caspase 3/7 activity normalized to the
control cells (NC) as means±1 S.D. (n¼ 3). Statistical analysis was carried out with the one-way ANOVA test followed by a Bonferonni post test. NS: no significantly different
from NC; ‘*’: significantly different from NC (0.054P40.01); ‘***’: significantly different from NC (Po0.001); ‘###’: significant difference between NT and HT (Po0.001).
(c) After 40 h of incubation, LDH release was assayed. Results are expressed as means±1 S.D. (n¼ 3). Statistical analysis was carried out with the one-way ANOVA test
followed by a Bonferonni post test. NS: no significantly different from NC; ‘***’: significantly different from NC (Po0.001); ‘##’: significant difference between NT and HT
(0.014P40.001)
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Figure 2 Taxol induces LC3II and p62 accumulation. MDA-MB-231 cells were incubated under normoxia (N) or hypoxia (H) without (C) or with taxol (T) at 50 mM. (a) After
2, 4, 8, 16 and 24 h of incubation, LC3 and p62 were detected in total cell extracts by western blotting analysis, using specific antibodies. b-actin was used to assess the total
amount of proteins loaded on the gel. The graphs below represent the quantification of the LC3II and p62 abundance normalized to the corresponding b-actin. (b) After 16 h of
incubation, cells were fixed, permeabilized and stained for LC3 (red) and LAMP1 (green) using specific antibodies. Nuclei were detected with To-Pro-3 (blue). (c) After 16 h
of incubation, lysosomal-dependent degradation was measured using DQ-Green-BSA dye. The histogram represents FL1 fluorescence intensity of unlabeled cells and cells
incubated in the presence of DQ-Green-BSA under normoxia (N) or hypoxia (H) with (T) or without (C) taxol. The graph below represents the medians of fluorescence value for
cells incubated under normoxia (N) or hypoxia (H) with (T) or without (C) taxol, without (grey columns) or with bafilomycin A (white columns)
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cells exposed to taxol under hypoxia are still able to manage
the stress, leading to less stressful conditions and to lower
p62 accumulation.
As autophagy seemed to be differentially activated under
normoxia and hypoxia, mTOR activity was studied to
investigate the upstream signaling responsible for autophagy
activation. The abundance of the phosphorylated forms of
mTOR and p70S6K (ribosomal protein S6 kinase, 70 kDa,
polypeptide 1; a target ofmTOR)wasassessed (Figure 3). Taxol
induced a decrease in p70S6K and mTOR phosphorylation
already after 2h and this decrease was time-dependent.
Moreover, the taxol-induced decrease in p70S6K and mTOR
phosphorylationwasenhanced in cells incubated under hypoxia.
These results confirm that the autophagic processwas activated
after taxol treatment and that hypoxia enhanced taxol-induced
autophagy activation.
Finally, we analyzed if p62 accumulation represented a
signaling event that could lead to cell death activation, as its
accumulation was more important in cells exposed to taxol
under normoxia. Cells were transfected with p62 siRNAs or
risc-free (RF) siRNA, used as a negative control. P62 protein
level was markedly reduced in p62 siRNA-transfected cells,
but its invalidation influenced neither autophagy induction
nor taxol-induced apoptosis and cell death (Supplementary
data 5).
Autophagy promotes resistance against taxol-induced
cell death in a Bnip3 independent way. As autophagy can
promote cell survival, we sought to determine the role of
taxol-induced autophagy in the modulation of cell death. For
this purpose, autophagy was inhibited using autophagy
related (Atg) 7 and Atg5 siRNA. Atg7 is the E2 enzyme
required for the ubiquitin-like conjugation of Atg5 to Atg12 at the
early step of autophagy activation. Cells were transfected with
either Atg7 or Atg5 siRNA, or RF siRNA, used as a negative
control, and incubated under normoxia or hypoxia with or
without taxol. Atg7 protein level was markedly reduced in Atg7
siRNA-transfected cells (Figure 4a). Atg7 invalidation prevented
autophagy induction by taxol as shown by a decrease in taxol-
induced conversion of LC3I to LC3II. On the other hand, Atg7
enhanced taxol-induced caspase 3 and PARP cleavage under
normoxia and hypoxia. Silencing of Atg7 also increased
caspase 3/7 activity (Figure 4b). Similar results were obtained
after Atg5 invalidation with siRNAs (Supplementary data 6).
These results suggest that autophagy inhibition resulted in
enhanced apoptosis.
In order to confirm the protective role of autophagy against
taxol-induced cell death, cells were incubated with rapamycin,
which inhibits the kinase mTOR and leads to autophagy
activation. Rapamycin led to a decrease in taxol-induced LDH
release under normoxia, to a lesser extent under hypoxia
(Figure 4d), and to a decrease in caspase 3 cleavage
(Figure 4c), suggesting that autophagy activation prevented
cell death. Altogether, these results indicate that autophagy
promotes resistance against taxol-induced cell death.
As BNIP3 has been shown to be involved in the induction of
pro-survival autophagy under hypoxia,16,38 we studied
whether BNIP3 and/or BNIP3L were involved in the regulation
of autophagy. Results showed that neither taxol, nor hypoxia
modified BNIP3L abundance. The role of this protein was thus
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not investigated further. On the other hand, BNIP3 abundance
markedly increased in the mitochondria containing fraction of
cells incubated under hypoxia for 24 h. The abundance was
even more increased in the presence of taxol (Supplementary
data 7). The role of BNIP3 was then investigated. Results
showed that BNIP3 silencing using siRNA had no clear cut
effect on apoptosis in cells incubated with taxol under hypoxia
(Supplementary data 8).
Taxol induces JNK activation and JNK-dependent Bcl2
and BclXL phosphorylation. Various reports showed that
taxol induces JNK activation.39–41 In order to investigate
whether taxol induced JNK activation and Bcl2/BclXL phos-
phorylation, the abundance of c-jun, Bcl2, BclXL and the
phosphorylated forms of these proteins was assessed by
western blotting using specific antibodies raised against JNK
phosphorylation sites (Figure 5a). Taxol induced c-jun, Bcl2
and BclXL phosphorylation at early time point under normoxia
and hypoxia, whereas a decrease in the abundance of these
phosphorylation forms was observed after 16 and 24 h under
hypoxia. JNK invalidation with siRNAs showed that Bcl2 and
BclXL phosphorylation was JNK-dependent, as JNK invalida-
tion (Supplementary data 9) resulted in a decrease in
phospho-Bcl2 and phospho-BclXL abundance (Figure 5b).
JNK promotes cell survival without being involved in
autophagy induction. As recent reports showed that JNK-
dependent phosphorylation of Bcl2 and BclXL can lead to cell
death and/or autophagy activation,24,42,43 the implication of
JNK in taxol-induced apoptosis and autophagy was investi-
gated after JNK silencing. Results showed that JNK inhibition
increased taxol-induced caspase 3 and PARP cleavage, as
well as caspase 3/7 activity and cytotoxicity under normoxia
and hypoxia. These data suggest that JNK activation
promoted cell survival after taxol exposure under normoxia
and hypoxia (Figure 6a–c).
The role of JNK activation in autophagy regulation was then
studied. JNK silencing resulted in a small increase in LC3II
abundance in cells incubated in the presence of taxol, as well
as to a decrease in p62 abundance only in cells incubated with
taxol under normoxia (Figure 7a). In addition, results showed
that JNK does not regulate autophagy induction, as no
modification in the fluorescence value corresponding to
DQ-BSA proteolysis was observed in cells transfected with
the JNK siRNA compared with untransfected cells when cells
were incubated with taxol (Figure 7b).
Neither Beclin 1 nor ATG5 cleavage is involved in
autophagy inhibition. It is reported that Beclin 1 and
ATG5 are cleaved during apoptosis and that this cleavage
can lead to autophagy inhibition or to apoptosis induction,
respectively.44,45 Supplementary data 10 shows that neither
taxol nor hypoxia induced calpain-mediated Atg5 cleavage
whatever the duration of the incubation. On the other hand,
western blot analysis showed that a cleaved fragment of
Beclin 1 appeared at an apparent molecular weight of about
41 kDa after 16 h of incubation (Supplementary data 11). In
order to investigate whether this cleavage is a consequence
of apoptosis induction, cells were incubated in the presence
of Z-VAD-fmk, a pan-caspase inhibitor. Results showed that
caspase inhibition prevented the apparition of the cleaved
fragment in cells incubated with taxol, indicating that it
is probably a consequence of apoptosis activation rather
than an event that participates to apoptosis induction
(Supplementary data 12). As the molecular weight of the
cleaved fragment was not the expected one, in silico analysis
using the SitePrediction website46 of the beclin 1 protein
sequence revealed several classical caspase recognition
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Figure 3 Hypoxia modulates taxol-induced autophagy. MDA-MB-231 cells were incubated under normoxia (N) or hypoxia (H) without (C) or with taxol (T) at 50 mM.
(a) After 2, 4, 8, 16 and 24 h of incubation, (phospho)-p70S6K and (phospho)-mTOR were detected in total cell extracts by western blotting analysis, using specific antibodies.
b-actin was used to assess the total amount of proteins loaded on the gel. The graphs below represent the quantification of phospho-p70S6K and phospho-mTOR abundance
normalized to b-actin relative to p70S6K and mTOR total abundance normalized to b-actin
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sites: of these, cleavage by caspase 3/7 after EASD105
would generate fragment of 40.3 kDa (Supplementary data 13).
Finally, we investigated whether beclin 1 cleavage by
caspases after long incubation time would be a negative
feedback mechanism leading to autophagy inhibition.
Results showed that LC3II and p62 abundance as well as
autophagic degradation remained unchanged in cells incu-
bated with Z-VAD-fmk compared with cells incubated without
the caspase inhibitor (Supplementary data 14). These results
showed that caspase-mediated cleavage of beclin 1 did not
have a role in autophagy inhibition.
Discussion
One largely studied factor promoting cancer cell resistance
against radiotherapy and chemotherapy is the development of
hypoxic regions within the tumor mass and subsequent
hypoxia-inducible factor-1 activation. In addition to hypoxia,
another process having a role in cancer resistance has been
highlighted in these past years, which is autophagy. Although
basal autophagy occurs in most cells, this process is also
activated by various stresses such as nutrient depletion,
hypoxia or chemotherapeutic treatment.12,47 Therefore, we
sought to evaluate the role of autophagy and hypoxia in the
taxol-induced apoptosis. Apoptosis was activated after 16 h of
incubation in the presence of taxol and hypoxia conferred
resistance against taxol-induced cell death. Autophagy was
also activated after taxol exposure, much earlier than
apoptosis. It should be noted that conflicting reports
exist about the effects of mitotic/microtubule inhibitors on
autophagy. Early studies interpreted increased number of
autophagosomes as evidence of autophagy induction,
whereas other studies as evidence of autophagic flow
inhibition.35,37,48–50 Therefore, autophagy kinetics was stu-
died. Results showed that taxol exposure led to autophagy
induction as shown by an increase in LC3II abundance, early
decrease in p62 abundance, mTOR inhibition and increase in
autophagic degradation. At longer incubation time, p62
accumulation observed in cells incubated in the presence of
taxol suggested that autophagy capacity was saturated. This
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relative caspase 3/7 activity normalized by fluorescence intensity of the control cells (NC X) and presented as means±1 S.D. (n¼ 3). Statistical analysis was carried out with
the two-way ANOVA test followed by a Bonferonni post test. NS: no significantly different from NC X; ‘#’: significant difference between NT X and HT X (0.054P40.01); NS:
no significant difference between HC SI and HC RF; ‘yy’: significant difference between NC SI and NC RF (NC 0.014P40.001); ‘yyy’: significant difference between NT SI
and NT RF, HT SI and HT RF (Po0.001). (c and d) MDA-MB-231 cells were incubated under normoxia (N) or hypoxia (H), without (C) or with taxol (T) at 50 mM combined or
not (X) with rapamycin (autophagy activator) at 100 nM (RAPA). (c) After 16 h of incubation, cleaved caspase 3 was detected in total cell extracts by western blotting analysis,
using specific antibodies. b-actin was used to assess the total amount of proteins loaded on the gel. (d) After 40 h of incubation, LDH release was assessed. Results are
expressed in percentage of viability as means±1 S.D. (n¼ 3). Statistical analysis was carried out with the two-way ANOVA test followed by a Bonferonni post test. NS: no
significantly different from NC X; ‘***’: significantly different from NC X (Po0.001); ‘##’: significant difference between NT X and HT X (0.014P40.001); ‘y’: significant
difference between HT X and HT RAPA (0.054P40.01); ‘yyy’: significant difference between NT X and NT RAPA (Po0.001)
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Figure 5 JNK-dependent phosphorylation of c-jun, Bcl2 and BclXL is induced by taxol but decreased after long incubation time under hypoxia. MDA-MB-231 cells were
incubated under normoxia (N) or hypoxia (H) without (C) or with taxol (T) at 50 mM. (a) After 2, 4, 8, 16 and 24 h of incubation, c-jun, Bcl2, BclXL, phospho-c-jun, phospho-Bcl2
and phospho-BclXL were detected in total cell extracts, obtained with a phospho-protein-specific lysis buffer, by western blotting analysis, using specific antibodies. b-actin was
used to assess the total amount of proteins loaded on the gel. The graphs below represent the quantification of phospho-c-jun, phospho-Bcl2 and phospho-BclXL abundance
normalized to b-actin relative to c-jun, Bcl2 and BclXL total abundance normalized to b-actin. (b) MDA-MB-231 cells were untransfected (X) or transfected with 25 nM of JNK1
and 25 nM of JNK2 siRNA (SI) or negative control RF siRNA at 50 nM (RF) for 24 h. The transfection media were removed and replaced by culture media for 24 h.
Cells were then incubated under normoxia (N) or hypoxia (H) for 16 h, without (C) or with taxol (T) at 50 mM. Bcl2, BclXL, phospho-Bcl2, phospho-BclXL were detected in total cell
extracts, obtained with a phospho-protein-specific lysis buffer, by western blotting analysis, using specific antibodies. b-actin was used to assess the total amount of proteins
loaded on the gel
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overloading was more important in cells incubated under
normoxia, resulting in stress persistence and apoptosis
activation. On the other hand, in cells incubated with taxol
under hypoxia, the autophagic flow was enhanced (as shown
by a more important mTOR inhibition), leading to more
efficient autophagic process, stress solving and no apoptosis
activation. Recently, Veldhoen et al.48 showed that taxol
inhibits autophagy in MCF-7 and SKBR3 cells, suggesting
that taxol inhibits basal autophagy rather than inducing it. This
inhibition was explained by the fact that taxol disturbs the
SI RFX XSI RFX SI RFX SI RF
NC NT HC HT
PARP
β-actin
β-actin
Cleaved
caspase 3
Cleaved PARP
Figure 6 JNK promotes cell survival against taxol-induced cell death. MDA-MB-231 cells were untransfected (X) or transfected with 25 nM of JNK1 and 25 nM of JNK2
siRNA (SI) or negative control RF siRNA at 50 nM (RF) for 24 h. The transfection media were removed and replaced by culture media for 24 h. Cells were then incubated under
normoxia (N) or hypoxia (H) for 16 h, without (C) or with taxol (T) at 50 mM. (a) After 16 h of incubation, PARP, cleaved PARP and cleaved caspase 3 were detected in total cell
extracts by western blotting analysis, using specific antibodies. b-actin was used to assess the total amount of proteins loaded on the gel. (b) After 16 h of incubation, caspase
3 and 7 activity was assayed by measuring fluorescence intensity associated to free AFC released from the cleavage of caspase 3 and 7 substrate Ac-DEVD-AFC. Results are
expressed in relative caspase 3/7 activity normalized by fluorescence intensity of the control cells (NC) and presented as means±1 S.D. (n¼ 3). Statistical analysis was
carried out with the two-way ANOVA test followed by a Bonferonni post test. NS: no significantly different from corresponding NC; ‘**’: significantly different from NC X
(0.014P40.001); ‘#’: significant difference between NT X and HT X (0.054P40.01); NS: no significant difference between NC SI and NC RF and between NT SI and NT
RF; ‘yy’: significant difference between HC SI and HC RF (0.014P40.001); ‘yyy’ significant difference between HT SI and HT RF (0.014P40.001). (c) After 40 h of
incubation, LDH release was assayed. Results are expressed as means±1 S.D. (n¼ 3). Statistical analysis was carried out with the two-way ANOVA test followed by a
Bonferonni post test. NS: no significantly different from NC X; ‘***’: significantly different from NC X (Po0.001); ‘###’: significant difference between NT X and HT X
(0.014P40.001); NS: no significant difference between NC SI and NC RF, HC SI and HC RF; ‘yy’ significant difference between HT SI and HT RF (0.014P40.001); ‘yyy’:
significant difference between NT SI and NT RF (Po0.001)
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Figure 7 JNK is not involved in taxol-induced autophagy activation. MDA-MB-231 cells were untransfected (X) or transfected with 25 nM of JNK1 and 25 nM of JNK2
siRNA (SI) or negative control RF siRNA at 50 nM (RF) for 24 h. The transfection media were removed and replaced by culture media for 24 h. Cells were then incubated under
normoxia (N) or hypoxia (H) for 16 h, without (C) or with taxol (T) at 50 mM. (a) LC3 and p62 were detected in total cell extracts, obtained with a phospho-protein-specific lysis
buffer, by western blotting analysis, using specific antibodies. b-actin was used to assess the total amount of proteins loaded on the gel. (b) Cells were incubated in the
presence of the DQ-Green-BSA fluorescent dye (unlabeled cells serve as a negative control). After incubation, cells were harvested and analyzed by flow cytometry
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microtubule network and autophagosome movement.
Another study showed that disruption of microtubules with
taxol led to a reduction in the number of mature autophago-
somes but did not affect their lifespan or their fusion with
lysosomes.35 A point in common between our work and
Veldhoen et al.48 study is that autophagy saturation is a
signaling event, leading to apoptosis activation, but the
mechanisms involved are not known. On the other hand, the
discrepancies regarding the effect of taxol on autophagy
induction could also be explained by the fact that the
concentration of taxol and the cell lines used were different.
Moreover, Veldhoen et al.48 did not measure autophagic
degradation quantitatively and did not study autophagy
kinetics at early time point. Regarding the effect of hypoxia,
similar observations as the once described here have been
made in previous studies, showing that hypoxia accelerates
the autophagic clearance of p62 protein and that an increase
in the turnover of acidic vesicles results in chemotherapy
resistance.51,52 We also showed that autophagy activation
promotes cell survival after taxol exposure, as Atg7 or Atg5
silencing resulted in a decrease in taxol-induced autophagy
and enhanced the taxol-induced apoptosis activation under
normoxia and hypoxia. This was confirmed by the fact that
activation of autophagy by rapamycin resulted in a decrease
in taxol-induced apoptosis and cell death.
In conclusion, apoptosis and autophagy are activated in
MDA-MB-231 cells after taxol exposure. Autophagy is
activated before apoptosis, suggesting that autophagy is first
activated as a protective mechanism followed by apoptosis
activation at longer time when the stress is not relieved.
Different mechanisms are known to regulate the switch
between autophagy and apoptosis. One of them involves
the activation of the JNK kinase and phosphorylation of two
members of the Bcl2 family: Bcl2 and BclXL.
24 Phosphorylation
of Bcl2 and BclXL located at the endoplasmic reticulum results
in autophagy induction, whereas apoptosis regulation is
restricted to Bcl2 and BclXL located at the mitochondria.
53
Another hypothesis proposes that activation of autophagy or
apoptosis is determined by the stress intensity. Indeed,
Wei et al.24 showed that after cell starvation, the association
between beclin 1 and Bcl2 is disrupted, due to JNK1-mediated
Bcl2 phosphorylation, thus promoting autophagy while phos-
phorylated Bcl2 is still able to interact with the pro-apoptotic
protein Bax inhibiting apoptosis. However, under extreme
conditions, JNK1 mediates hyper-phosphorylation of Bcl2,
which detaches from Bax, thus facilitating apoptosis and
consequently cell death. Moreover, studies describe a dual
role for the JNK kinase in apoptosis regulation.54 In some
reports, taxol-induced JNK activation and Bcl2 phosphoryla-
tion led to cell death, whereas in other reports, JNK activation
resulted in cell survival.40,55–57 Furthermore, Ventura et al.58
showed that after TNFa stimulation, early JNK activation
promoted survival, whereas prolonged activation of JNK led to
cell death. Here, we showed that taxol induced JNK-
dependent phosphorylation of Bcl2 and BclXL very rapidly
under normoxia and hypoxia, and that the abundance of the
phosphorylated forms of Bcl2 and BclXL was decreased after
longer incubation time under hypoxia. In parallel, JNK
invalidation led to an increase in apoptosis and cell death
under normoxia and hypoxia, suggesting that taxol-induced
JNK activation promotes cell survival. It could be envisaged
that early JNK activation promotes cell survival under
normoxia and hypoxia, whereas the sustained JNK activation
observed under normoxia can be coupled to prolonged Bcl2
phosphorylation and apoptosis. The connection between JNK
activation and autophagy regulation was also studied. No link
between JNK activation and autophagy induction after taxol
exposure was evidenced, suggesting that JNK is involved in
the mechanisms leading to resistance against taxol-induced
cell death but not by being involved in autophagy induction.
Atg5 and beclin 1 cleavage was also investigated but no
cleavage of these proteins was evidenced as being involved in
a delayed autophagy inhibition.
In conclusion, taxol induces apoptosis and autophagy
activation. Cells incubated under hypoxia are resistant against
taxol-induced apoptosis. Autophagy, which is activated earlier
than apoptosis, promotes cell survival against taxol-induced
cell death under normoxia and hypoxia. The resistance
against taxol-induced cell death under hypoxia can be
explained by a more efficient autophagic process; which is
activated via the classical pathway, that is, via mTOR
inhibition but not by JNK activation. Under normoxia,
autophagic degradation is less efficient, leading to autophagy
saturation, p62 accumulation, persistence of JNK activation
and Bcl2/BclXL phosphorylation. The intracellular stress
induced by taxol exceeds a certain threshold, leading to
apoptosis activation and cell death (Figure 8).
Materials and Methods
Cell culture and hypoxia incubation. Human breast cancer cells MDA-
MB-231 were maintained in culture in 75 cm2 polystyrene flasks (Costar, Lowell,
MA, USA) with 15ml of Roswell Park Memorial Institute medium (RPMI 1640
Invitrogen, Carlsbad, CA, USA; cat. no. 21875) containing 10% of fetal calf serum
(Invitrogen, cat. no. 10270) and incubated under an atmosphere containing 5% CO2.
For hypoxia experiments (1% O2), cells were incubated in serum-free
CO2-independent medium (Invitrogen, cat. no. 18045) supplemented with 1mM
L-glutamine (Sigma, St. Louis, USA; cat. no. G3126) with or without paclitaxel
Normoxia
Hypoxia
Cell death
TAXOL
JNK
activation
AUTOPHAGY
Cell survival
APOPTOSIS
Threshold
Bcl2/BclXL
Phosphorylation
p62 accumulation
Caspase activation
Autophagy
activation
MDA-MB-231
cells
Figure 8 Schematic representation of the lower sensibility of MDA-MB-231 cells
against taxol induced cell death under hypoxia. Taxol induces autophagy activation
and this activation promotes cell survival against taxol-induced cell death under
normoxia and hypoxia. However, under hypoxia autophagy seems to be activated in
a more efficient way leading to a more active autophagic flow and solving of the
stress, resulting in lower p62 abundance, lower Bcl2 and BclXL phosphorylation and
lower apoptosis activation. In contrast, under normoxia the autophagic flow seems
to be saturated, the stress is not properly resolved and exceeds the threshold. P62
accumulation and Bcl2/BclXL phosphorylation persists, leading to apoptosis
activation and cell death
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(Molecular Probes, Carlsbad, CA, USA; cat. no. P3456) at 50 mM. Normoxic control
cells were incubated in the same conditions but in normal atmosphere (20% O2).
For some experiments, bafilomycin A1 (100 nM; Sigma, cat. no. B1793),
rapamycin (100 nM; Sigma, cat. no. R8781), pepstatin A (10 mg/ml; Sigma, cat. no.
P4265), E64D (10 mg/ml; Sigma, cat. no. E8640) or actinomycin D (5mg/ml; Sigma,
cat. no. A9415) were added to the medium.
Caspase 3 activity assay. The fluorogenic substrate Ac-DEVD-AFC was
used to measure caspase 3 activity according to Lozano et al.59 Cell extracts were
prepared as described by Wellington et al.60 Cells were seeded in 25 cm2
polystyrene flasks (Costar; 800 000 cells/well) 1 day before the incubation. After
the incubation, the medium was recovered and centrifuged at 1 000 g for 5 min.
Cells still attached to the well were scrapped in 500ml cold PBS and recovered
into a microtube. Pelleted detached cells were resuspended in 100 ml PBS at 4 1C
and also added to the microtube. The samples were centrifuged at 1 000 g for
5 min at 4 1C and the pellet resuspended in 50ml of lysis buffer (10mM Hepes/
KOH (pH 7.0), 10% sucrose, 2 mM EDTA, 0.1% CHAPS, 5 mM dithiothreitol and
10mg/ml aprotinin). After incubation at 4 1C on a rotating wheel for 15min, the
lysates were centrifuged at 13 000 g for 5 min at 4 1C and the supernatants
were recovered for the assay.
The protein concentration was measured and 10 mg proteins completed to 50ml
with lysis buffer were mixed with 13 mM Ac-DEVD-AFC (BD Pharmingen, Franklin
Lakes, NJ, USA; cat. no. 556574) and 50 ml reaction buffer (40mM PIPES (pH 7.2),
200mM NaCl, 2 mM EDTA, 0.2% CHAPS, 0.10% sucrose and 10mM
dithiothreitol). The reaction was allowed to take place for 1 h at 37 1C and the
fluorescence generated by the release of the fluorogenic group AFC on cleavage by
caspase 3 was measured by excitation at 400 nm and emission at 505 nm.
LDH release assay. LDH release was measured with the cytotoxicity
detection kit from Roche Molecular Biochemicals (Basel, Switzerland) according to
the manufacturer’s protocol. Cells were seeded in six-well plates (200 000 cells/
well) 1 day before the incubation. The culture media from incubated cells were
removed and centrifuged to pellet the cell fragments and apoptotic bodies. In order
to lyse the cells, Triton X-100 (Merck, Billerica, MA, USA) at 10% in PBS was
added on this pellet, as well as on the cells remaining in the wells. The percentage
LDH release was calculated as follows:
LDH activity in medium (1)þ LDH activity of cell fragments (2)/(1)þ (2)þ LDH
activity of cells remaining in the wells.
Immunofluorescence labeling and confocal microscopy. MDA-
MB-231 cells were seeded at 30 000 cells/well in 24-well plates containing a
coverslip, 24 h before incubation. Cells were incubated for 16 h with or without
taxol under normoxic or hypoxic conditions. After incubation, cells were fixed and
permeabilized 10min with a cold solution of 80% methanol and 20% acetone,
washed three times with 2% PBS–BSA and incubated for 2 h with primary
antibodies. Primary antibody for LC3 staining was rabbit anti-LC3 (Sigma, cat. no.
L7543; 1/250 dilution) and primary antibody for LAMP1 staining was mouse anti-
LAMP1 (H4A3-c Developmental Studies Hybridoma Bank; 1/250 dilution). Cells
were washed three times with 2% PBS–BSA and then incubated for 1 h with
secondary antibodies. Alexa Fluor-488-conjugated anti-rabbit IgG antibody
(Molecular Probes) was used at 1/1000 dilution and Alexa Fluor-546-conjugated
anti-mouse IgG antibody (Molecular Probes) was used at 1/1000 dilution. Cells
were then washed three times with PBS, the coverslips were mounted in Mowiol
(Sigma) and observed with a confocal microscope.
Western blotting. Cells, seeded and incubated in 25 cm2 flasks, were
scrapped in 200ml of lysis buffer (Tris 40mM (pH 7.5), KCl 150mM, EDTA 1mM,
Triton X-100 1%) or phospho-protein-specific lysis buffer (Tris HCl 25mM (pH 7.4),
NaCl 150mM, EDTA 1mM, NP 1%, glycerol 5%) containing a protease inhibitor
mixture ()Complete* from Roche Molecular Biochemicals, one tablet in 2 ml H2O,
added at a 1/25 dilution) and phosphatase inhibitors (NaVO3 25mM, p-nitrophenyl
phosphate 250mM, b-glycerophosphate 250mM and NaF 125mM, at a 1/25
dilution). Cell lysate was recovered and centrifuged for 5min at 13 000 r.p.m. at
4 1C to pellet the cell debris. The supernatant was collected for protein assay and
western blot analysis. A measure of 15 or 20 mg of proteins were loaded on a
NuPage 4–12% (Invitrogen) for cleaved caspase 3 or on 12% SDS-PAGE for the
other proteins. After migration, proteins were transferred onto a low fluorescence
background polyvinylidene fluoride membrane (Millipore, Billerica, MA, USA) at
1mA/cm2 during 2 h. Membranes were blocked with Odyssey blocking buffer (BD
Biosciences, Franklin Lakes, NJ, USA) diluted 2 in PBS for 1 h at RT. Primary
antibodies diluted in Odyssey blocking buffer 0, 1% Tween (Sigma) were
incubated O.N. at 4 1C with membranes washed four times with PBS-Tween 0, 1%
and then incubated with secondary antibodies for 1 h at RT. Membranes were
washed four times with PBS-Tween 0, 1%, twice with PBS and then dried 1 h at
37 1C, and revealed in the Odyssey Licor. Primary antibodies are mouse anti-
PARP-1 monoclonal antibody (BD Pharmingen, cat. no. 556493), rabbit anti Atg7
polyclonal antibody (Cell Signaling, Danvers, MA, USA; cat. no. 2631), rabbit anti-
Atg5 antibody (Cell Signaling, cat. no. 2630), mouse anti-LC3 antibody (0231-100/
LC3-5F10 from Nanotools, Munich, Germany), rabbit anti-caspase 3 antibody
(Cell Signaling, cat. no. 9662m ), rabbit anti-c-jun antibody (cat. no. 9165 from Cell
Signaling), mouse anti-BclXL antibody (Sigma, cat. no. B9429), rabbit anti-Bcl2
antibody (Cell Signaling, cat. no. 2870), rabbit anti-phospho-c-jun antibody
(Cell Signaling, cat. no. 9261), rabbit anti-phospho-Bcl2 monoclonal antibody (Cell
Signaling, cat. no. 2827), rabbit anti-phospho-BclXL polyclonal antibody (Millipore,
cat. no. AB3116), mouse anti-p62/SQSTM1 antibody (H00008878-M03 from
Abnova, Tapei, Taiwan), rabbit anti-phospho-p70S6K antibody (Cell Signaling, cat.
no. 9205from), rabbit anti-p70S6K antibody (Cell Signaling, cat. no. 9202), rabbit
anti-phospho-mTOR antibody (Cell Signaling, cat. no. 2971), rabbit anti-mTOR
antibody (Cell Signaling, cat. no. 2972), rabbit anti-Atg5 antibody (NB110-53818
from Novus Biological, Littleton, CO, USA), mouse anti-Beclin 1 antibody (BD
Transduction Laboratories, Franklin Lakes, NJ, USA; cat. no. 612112), mouse
anti-Bnip3 antibody (MAB4147 from R&D Systems, Minneapolis, MN, USA), rabbit
anti-Bnip3L antibody (ab8399 from Abcam, Cambridge, UK). Mouse anti-b-actin
antibody (Sigma, cat. no. A5441) and rabbit anti-TOM40 antibody (Santa Cruz
Technologies, Dallas, TX, USA; cat. no. 11414) were used for normalization.
IRDye 800CW-conjugated goat anti-rabbit antibody (Hþ L; Licor, Lincoln, NE,
USA; cat. no. 926-32211), IRDye 800CW-conjugated goat anti-mouse antibody
(Hþ L; Licor, cat. no. 926-32210), IRDye 680LT-conjugated goat anti-rabbit
antibody (Hþ L; Licor, cat. no. 926-68021) and IRDye 680LT-conjugated goat
anti-mouse antibody (Hþ L; Licor, cat. no. 926-68020) were used at 1/10000
dilution as secondary antibodies. Quantitative analysis of fluorescence intensity
was measured using the Odyssey Classic Infrared Imaging System (Licor).
Real time RT-PCR. After the incubation, total RNA was extracted according
to the manufacturer’s protocol using the QIAcube (Qiagen, Hilden, Germany).
mRNA contained in 2 mg total RNA was reverse transcribed using SuperScript II
Reverse Transcriptase (Invitrogen) and oligodT primers according to the
manufacturer’s instructions. Forward and reverse primers for RPL13A and p62
were designed using the Primer Express 1.5 software (Applied Biosystems,
Carlsbad, CA, USA). Amplification reaction assays contained 1 SYBR Green
PCR Faststart universal (Roche, Basel, Switzerland) and primers (Applied
Biosystems) at the optimal concentrations. A hot start at 95 1C for 5min was
followed by 40 cycles at 95 1C for 15 s and 65 1C for 1min using an ABI PRISM
7000 SDS thermal cycler (Applied Biosystems). RPL13A was used as the
reference gene for normalization and mRNA expression level was quantified using
the threshold cycle method.
siRNA transfection. Silencing of Atg7, Atg5, JNK1 and JNK2 and p62
expression was achieved using ON-TARGET plus SMARTpool human Atg7
(Dharmacon, Lafayette, CO, USA; cat. no. L020112), SMARTpool siGENOME
human Atg5 (Dharmacon, cat. no. M00437404), ON-TARGET plus SMARTpool
human MAPK8 (JNK1; Dharmacon, cat. no. L003514) and ON-TARGET plus
SMARTpool human MAPK9 (JNK2; Dharmacon, cat. no. L003505), ON-TARGET
plus SMARTpool human SQSTM1 (p62; Dharmacon, cat no. L010230). RF control
siRNA purchased from Dharmacon was used to control for non-specific effects.
For siRNA experiments, 8 105 cells were seeded in 25 cm2 polystyrene flasks
(Costar) with 4 ml of RPMI 1640 medium containing 10% of fetal calf serum and
incubated for 24 h under an atmosphere containing 5% CO2. Cells were then
transfected for 24 h under standard culture conditions with 50 nM siRNA using the
DharmaFECT 1 (Dharmacon) transfection reagent according to the manufacturer’s
instructions. The transfection media were removed and replaced by culture media
for 24 h. Cells were then incubated as previously described.
DQ-Green-BSA proteolysis assay. Lysosomal-dependent proteolysis
was visualized by the use of self-quenched Bodipy dye conjugates of BSA
(DQ-BSA, D-12050 from Molecular Probes). Cells were plated in Lab-tek (for
confocal microscopy) or in six-well plate (for flow cytometry), 24 h before the
incubation. Cells were incubated under normoxia or hypoxia with or without taxol
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and/or bafilomycin A. DQ-Green-BSA dye was added to each well at a
concentration of 50mg/ml. A well without DQ-Green-BSA served as a negative
control. After the incubation, lysotracker red were added at a concentration of
100 nM for 20min before imaging with confocal microscopy or cells were
harvested and analyzed by flow cytometry.
Flow cytometry. After the incubation, cells were rinsed with PBS, trypsinized
and rinsed with PBS again. Cells were analyzed by flow cytometry with a
FACScalibur (BD Biosciences), using FL1-H channel for DQ-Green-BSA
fluorescence. The median was calculated for each condition using the Cell Quest
Pro software. Results are expressed as median value for each condition.
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